| Christopher Damelio, | |
|
565 Abbott Rd, Buffalo, NY 14220-2039 | |
| (716) 826-7000 | |
| Not Available |
| Full Name | Christopher Damelio |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Location | 565 Abbott Rd, Buffalo, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003696477 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | F353265-01 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Damelio, 307 S Evergreen Ave, Woodbury, NJ 08096-2739 Ph: () - | Christopher Damelio, 565 Abbott Rd, Buffalo, NY 14220-2039 Ph: (716) 826-7000 |
News Archive
The antiviral drug peramivir might offer humans significant protection during a pandemic of the avian influenza virus H5N1, according to results of mouse studies conducted by investigators at St. Jude Children's Research Hospital.
New research indicates that adults born very premature are more likely to be socially withdrawn and display signs of autism.
Adenocarcinoma histology, female sex, never-smoking status, and Asian ethnicity have been considered the most important factors associated with EGFR mutations in non-small cell lung cancer and response to EGFR inhibitors. A recent study has found that, within the Asian population, the frequency of EGFR mutations associated with other demographic and clinical characteristics is higher than previously reported, even in patients with a history of smoking, suggesting that mutation testing should be done on a broader basis among Asian patients with advanced adenocarcinoma of the lung.
Prothelia Incorporated and University of Nevada, Reno announce that they have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient congenital muscular dystrophy (MDC1A), a life-threatening, ultra-rare disease caused by a genetic deficiency of the Laminin-211 protein.
Touchstone Health Partnership, a managed care company primarily operating in the Medicare Advantage Program, today announced the appointment of Bryan D. Birch as President and Chief Executive Officer. Mr. Birch brings over 20 years of experience in the health services and managed care sector.
› Verified 8 days ago
Mr. V. Thomas Chapin, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 462 Grider St, Buffalo, NY 14215 Phone: 716-898-3000 | |
Beth Lyn Vaccarelli, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 701 Seneca St Ste 646c, Buffalo, NY 14210 Phone: 716-995-4450 | |
Ms. Denise Marie Donahue, NURSE PRACTITIONER Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 High St, Buffalo, NY 14203 Phone: 716-859-5600 | |
Mr. Jerry L Corp Ii, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 255 Delaware Ave, Buffalo, NY 14202 Phone: 716-884-0888 | |
Stephanie Erin Myszka, F.N.P.- BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 | |
Jessica Lynn Hafezi, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Elm And Carlton Streets, Buffalo, NY 14263 Phone: 716-845-2300 | |
Yevgeniya S Lipina, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 701 Seneca St Ste 646c, Buffalo, NY 14210 Phone: 716-995-4450 Fax: 844-206-7424 |